161 related articles for article (PubMed ID: 33634858)
1. Neoadjuvant therapy for gastrointestinal stromal tumors: A propensity score-weighted analysis.
Marqueen KE; Moshier E; Buckstein M; Ang C
Int J Cancer; 2021 Jul; 149(1):177-185. PubMed ID: 33634858
[TBL] [Abstract][Full Text] [Related]
2. Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis.
Ling JY; Ding MM; Yang ZF; Zhao YD; Xie XY; Shi LS; Wang HM; Cao WT; Zhang JW; Hu HB; Cai Y; Wang H; Deng YH
J Surg Oncol; 2021 Dec; 124(8):1442-1450. PubMed ID: 34494280
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant therapy versus upfront surgery for early-stage left-sided pancreatic adenocarcinoma: A propensity-matched analysis from a national cohort of distal pancreatectomies.
Nassour I; Adam MA; Kowalsky S; Al Masri S; Bahary N; Singhi AD; Lee K; Zureikat A; Paniccia A
J Surg Oncol; 2021 Jan; 123(1):245-251. PubMed ID: 33103242
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis.
Mokdad AA; Minter RM; Zhu H; Augustine MM; Porembka MR; Wang SC; Yopp AC; Mansour JC; Choti MA; Polanco PM
J Clin Oncol; 2017 Feb; 35(5):515-522. PubMed ID: 27621388
[TBL] [Abstract][Full Text] [Related]
5. [A multicentre retrospective cohort study of patients with gastrointestinal stromal tumors in Shandong Province].
Ning L; Yan W; Zhang M; Gong H; Dai Y; Jiang L; Lin H; Zhang D; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):326-30. PubMed ID: 24760638
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor.
Ling J; Shi L; Cheng X; Fu Y; Lin Z; Zhao Y; Li Z; Zhang J; Hu H; Cai Y; Deng Y
J Gastrointest Oncol; 2023 Feb; 14(1):73-84. PubMed ID: 36915468
[TBL] [Abstract][Full Text] [Related]
7. Rectal GIST-Outcomes and viewpoint from a tertiary cancer center.
Zanwar S; Ostwal V; Sahu A; Jain D; Ramaswamy A; Saklani A; Ramadwar M; Shetty N; Shrikande SV
Indian J Gastroenterol; 2016 Nov; 35(6):445-449. PubMed ID: 27783353
[TBL] [Abstract][Full Text] [Related]
8. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.
Cavnar MJ; Wang L; Balachandran VP; Antonescu CR; Tap WD; Keohan M; Singer S; Temple L; Nash GM; Weiser MR; Guillem JG; Aguilar JG; DeMatteo RP; Paty PB
Ann Surg Oncol; 2017 Dec; 24(13):3972-3980. PubMed ID: 29058144
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].
Li XQ; Tu L; Wang M; Ma XL; Yang LX; Shen YY; Zhuang C; Zhao WY; Qiu JF; Zhao G; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):872-879. PubMed ID: 32927512
[No Abstract] [Full Text] [Related]
10. Survival impact of neoadjuvant therapy in resected pancreatic cancer: A Prospective Cohort Study involving 18,332 patients from the National Cancer Data Base.
Mirkin KA; Hollenbeak CS; Wong J
Int J Surg; 2016 Oct; 34():96-102. PubMed ID: 27573691
[TBL] [Abstract][Full Text] [Related]
11. Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort.
IJzerman NS; Mohammadi M; Tzanis D; Gelderblom H; Fiore M; Fumagalli E; Rutkowski P; Bylina E; Zavrakidis I; Steeghs N; Bonenkamp HJ; van Etten B; Grünhagen DJ; Rasheed S; Tekkis P; Honoré C; van Houdt W; van der Hage J; Bonvalot S; Schrage Y; Smith M
Eur J Surg Oncol; 2020 Jun; 46(6):1124-1130. PubMed ID: 32224070
[TBL] [Abstract][Full Text] [Related]
12. Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery.
Nagakawa Y; Sahara Y; Hosokawa Y; Murakami Y; Yamaue H; Satoi S; Unno M; Isaji S; Endo I; Sho M; Fujii T; Takishita C; Hijikata Y; Suzuki S; Kawachi S; Katsumata K; Ohta T; Nagakawa T; Tsuchida A
Ann Surg Oncol; 2019 Jun; 26(6):1629-1636. PubMed ID: 30610555
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant tyrosine kinase inhibitor therapy for patients with gastrointestinal stromal tumor: A propensity-matched analysis.
Wong LH; Sutton TL; Sheppard BC; Corless CL; Heinrich MC; Mayo SC
Am J Surg; 2022 Jul; 224(1 Pt B):624-628. PubMed ID: 35382931
[TBL] [Abstract][Full Text] [Related]
14. Is nonanatomic rectal resection a valid therapeutic option for rectal gastrointestinal stromal tumors? A proposed decision algorithm.
Romain B; Delhorme JB; Manceau G; Lefevre JH; Tresallet C; Mariani P; Iannelli A; Rouanet P; Piessen G; Brigand C;
J Surg Oncol; 2020 Dec; 122(8):1639-1646. PubMed ID: 33184896
[TBL] [Abstract][Full Text] [Related]
15. Is multivisceral resection in locally advanced gastrointestinal stromal tumours an acceptable strategy?
Wong JSM; Tan GHC; Quek R; Goh BKP; Kwok LL; Kumar M; Soo KC; Teo MCC
ANZ J Surg; 2017 Jun; 87(6):477-482. PubMed ID: 27226158
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
[TBL] [Abstract][Full Text] [Related]
18. Utilization of Neoadjuvant Therapy in Gastrointestinal Stromal Tumors of the Stomach: Analysis of the 2006-2018 National Cancer Database.
Kelly CH; Sipok A; Landry JP; Ramsey L; Joyce CJ; Gnerlich JL
J Gastrointest Surg; 2023 Sep; 27(9):1794-1803. PubMed ID: 37316761
[TBL] [Abstract][Full Text] [Related]
19. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.
Cools KS; Sanoff HK; Kim HJ; Yeh JJ; Stitzenberg KB
J Surg Oncol; 2018 Sep; 118(3):455-462. PubMed ID: 30114330
[TBL] [Abstract][Full Text] [Related]
20. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
[No Abstract] [Full Text] [Related]
[Next] [New Search]
